Asset Details
Do you wish to reserve the book?
Comprehensive Screening of a North American Parkinson’s Disease Cohort for LRRK2 Mutation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Comprehensive Screening of a North American Parkinson’s Disease Cohort for LRRK2 Mutation
Do you wish to request the book?
Comprehensive Screening of a North American Parkinson’s Disease Cohort for LRRK2 Mutation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Comprehensive Screening of a North American Parkinson’s Disease Cohort for LRRK2 Mutation
2007
Overview
Background: Recently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism. Objective: To identify mutations causing Parkinson’s disease (PD) in a cohort of North Americans with familial PD. Methods: We sequenced exons 1–51 of LRRK2 in 79 unrelated North American PD patients reporting a family history of the disease. Results: One patient had a missense mutation (Thr2356Ile) while two others had the common Gly2019Ser mutation. In addition, 1 patient had a 4-bp deletion in close proximity to the exon 19 splice donor (IVS20+4delGTAA) that in vitro abrogates normal splicing. Conclusions: Our observations in the 79 North American patients indicate that mutations in LRRK2 are associated with approximately 5% of PD cases with a positive family history. The results also show that G2019S represents approximately half of the LRRK2 mutations in United States PD cases with a family history of the disease. We have identified two novel mutations in LRRK2.
Publisher
S. Karger AG
Subject
/ Adult
/ Aged
/ Alternative Splicing - genetics
/ Amino Acid Substitution - genetics
/ Genetic Predisposition to Disease - genetics
/ Humans
/ Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
/ Male
/ Mutation, Missense - genetics
/ Parkinson Disease - genetics
/ Parkinson Disease - metabolism
/ Parkinson Disease - physiopathology
